Table 3.

All-cause mortality among CHS participants with eGFRcreat <60 ml/min per 1.73 m2 at year 7 by albuminuria and eGFRcys

nEventsHR (95% CI)
Demographic AdjustedaFully Adjustedb
eGFRcys ≥60 and alb/cr <30170711.00 (ref)1.00 (ref)
eGFRcys ≥60 and alb/cr >3039292.01 (1.29, 3.14)1.94 (1.23, 3.04)
eGFRcys <60 and alb/cr <303802621.74 (1.30, 2.29)1.71 (1.30, 2.25)
eGFRcys <60 and alb/cr >302001813.72 (2.80, 4.96)3.41 (2.54, 4.59)
  • Median follow-up time was 10.14 years. ref, referent group.

  • aAdjusted for age, gender, and race.

  • bAdjusted age, gender, race, diabetes, smoking, total cholesterol, body mass index, prevalent CVD, and C-reactive protein.